Abstract
A bruising battle for scarce research dollars is being waged among competing advocacy groups that seek cures for dread diseases. Many activists are unwilling to leave decisions to the scientists. They want Congress to decide which diseases deserve the most bucks.
摘要
在竞相寻求攻克可怕疾病方法的各倡导团体之间，正展开一场争夺稀缺研究资金的激烈斗争。许多活动人士不愿将决策权交给科学家。他们希望国会来决定哪些疾病应获得最多资金。
相似文献
1
Biomedical warfare.生物医学战。
Natl J (Wash). 1997 Feb 1;29(5):220-3.
2
Outlining a new path for research.
Natl J (Wash). 1996 Mar 30;28(13):713, 716.
3
Disease-of-the-month alive and well.本月疾病依然存在。
Nature. 1992 Nov 5;360(6399):13. doi: 10.1038/360013a0.
4
Opponents of US earmarks propose reviews to temper worst elements of growing practice.美国专项拨款的反对者提议进行审查，以遏制这种不断发展的做法中最恶劣的部分。
Nature. 1992 Nov 5;360(6399):4-5. doi: 10.1038/360004a0.
5
6
Setting priorities for research is no easy task at NIH.在美国国立卫生研究院，确定研究的优先事项并非易事。
J Natl Cancer Inst. 1997 Sep 17;89(18):1338-9.
7
AIDs, activism, and the politics of health.
N Engl J Med. 1992 Jan 9;326(2):128-33. doi: 10.1056/NEJM199201093260209.
8
Congressional rites of passage for the rights of alcoholics.
Alcohol Health Res World. 1988 Summer;12(4):240-51.
9
Alzheimer's disease. Getting on the federal agenda.阿尔茨海默病。被提上联邦议程。
Caring. 1991 Dec;10(12):4-8, 10.
10
Mental health advocates complain about NIMH priority for AIDS. National Institute of Mental Health.心理健康倡导者抱怨美国国立精神卫生研究所将艾滋病列为优先事项。美国国立精神卫生研究所。
AIDS Policy Law. 2000 Jan 21;15(1):5.
Zotero 插件